Agenda Management Committee Meeting
COST Action BM1007 "Mast Cells and Basophils - Targets for Innovative Therapies", Southampton UK, the 24-11-2011
0. Welcome to participants
1. Adoption of agenda
2. Minutes of last meeting
3. Matters arising
4. Report from the COST Office
- News from the COST Office
- Status of Action, including participating countries
- Budget status, budget planning and allocation process (Grant Holder report)
5. Action budget planning status
6. STSM status, applications
7. Publications, annual report
8. Evaluations
9. Request for new members
10. Promotion of gender balance and of Early Stage Researchers (ESR)
11. Non-COST country participations
12. Web news
13. Progress report of working groups
14. Long-term planning
15. Place and date of next meeting
16. AOB
17. Closing
Download Agenda [PDF]News & Events
COST Action BM1007 WG1 Meeting
Dear All WG1 Members and Chairs WG2,3,4,
We are pleased to invite you to a COST Action BM1007 WG1 Meeting on May 19-20, 2012. The meeting will take place in the Institute of Molecular Genetics...
Applications for Short Term Scientific Missions 2011/2012
The COST Action BM 1007 provides young and early stage researchers with individual support to conduct scientific und educational exchange between partner laboratories. For Short Term Scientific...
European Histamine Research Society and COST Action BM0806 Joint Meeting
Belfast, Ireland, May 2-5, 2012
International Mast Cell and Basophil Meeting 2011 in partnership to the COST Annual Conference on Mast Cells and Basophils 2011
24-25th November, 2011, Southampton, UK. Mast Cells and Basophils as Targets for Innovative Therapies.
Reports
COST Action BM1007 Meeting
Abstracts and Impressions of the COST Action BM1007 Meeting, Southampton UK, 24-11-2011
Agenda Management Committee Meeting
COST Action BM1007 "Mast Cells and Basophils - Targets for Innovative Therapies", Southampton UK, the 24-11-2011
Project support by national COST Grant in Poland
The clinical application of gene expression in the treatment of insect venom allergy, diagnosis and the assessment of the risk of anaphylaxis in patient with mastocytosis.
Minutes
First Meeting of the Management Committee of COST Action BM1007: MAST CELLS AND BASOPHILS – TARGETS FOR INNOVATIVE THERAPIES
Brussels, 16.03.2011
